BLFS
Price
$26.42
Change
-$0.97 (-3.54%)
Updated
Dec 23, 04:59 PM (EDT)
80 days until earnings call
DCTH
Price
$11.44
Change
+$0.43 (+3.91%)
Updated
Dec 23, 04:59 PM (EDT)
99 days until earnings call
Ad is loading...

BLFS vs DCTH

Header iconBLFS vs DCTH Comparison
Open Charts BLFS vs DCTHBanner chart's image
BioLife Solutions
Price$26.42
Change-$0.97 (-3.54%)
Volume$3.57K
CapitalizationN/A
Delcath Systems
Price$11.44
Change+$0.43 (+3.91%)
Volume$3.6K
CapitalizationN/A
BLFS vs DCTH Comparison Chart
Loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DCTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLFS vs. DCTH commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLFS is a Hold and DCTH is a Hold.

COMPARISON
Comparison
Dec 24, 2024
Stock price -- (BLFS: $27.39 vs. DCTH: $11.01)
Brand notoriety: BLFS and DCTH are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BLFS: 245% vs. DCTH: 107%
Market capitalization -- BLFS: $810.87M vs. DCTH: $109.8M
BLFS [@Medical Specialties] is valued at $810.87M. DCTH’s [@Medical Specialties] market capitalization is $109.8M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLFS’s FA Score shows that 1 FA rating(s) are green whileDCTH’s FA Score has 1 green FA rating(s).

  • BLFS’s FA Score: 1 green, 4 red.
  • DCTH’s FA Score: 1 green, 4 red.
According to our system of comparison, both BLFS and DCTH are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLFS’s TA Score shows that 6 TA indicator(s) are bullish while DCTH’s TA Score has 6 bullish TA indicator(s).

  • BLFS’s TA Score: 6 bullish, 3 bearish.
  • DCTH’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, BLFS is a better buy in the short-term than DCTH.

Price Growth

BLFS (@Medical Specialties) experienced а +2.58% price change this week, while DCTH (@Medical Specialties) price change was -9.08% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.55%. For the same industry, the average monthly price growth was +0.22%, and the average quarterly price growth was +2.20%.

Reported Earning Dates

BLFS is expected to report earnings on Mar 13, 2025.

DCTH is expected to report earnings on Apr 01, 2025.

Industries' Descriptions

@Medical Specialties (-0.55% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLFS($811M) has a higher market cap than DCTH($110M). BLFS has higher P/E ratio than DCTH: BLFS (238.10) vs DCTH (212.77). DCTH YTD gains are higher at: 164.663 vs. BLFS (68.554). BLFS (-45.24M) and DCTH (-46.11M) have comparable annual earnings (EBITDA) . BLFS has more cash in the bank: 51.7M vs. DCTH (32.5M). DCTH has less debt than BLFS: DCTH (10.2M) vs BLFS (42.7M). BLFS has higher revenues than DCTH: BLFS (143M) vs DCTH (2.07M).
BLFSDCTHBLFS / DCTH
Capitalization811M110M737%
EBITDA-45.24M-46.11M98%
Gain YTD68.554164.66342%
P/E Ratio238.10212.77112%
Revenue143M2.07M6,925%
Total Cash51.7M32.5M159%
Total Debt42.7M10.2M419%
FUNDAMENTALS RATINGS
BLFS vs DCTH: Fundamental Ratings
BLFS
DCTH
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
89
Overvalued
PROFIT vs RISK RATING
1..100
74100
SMR RATING
1..100
9499
PRICE GROWTH RATING
1..100
3936
P/E GROWTH RATING
1..100
141
SEASONALITY SCORE
1..100
2050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DCTH's Valuation (89) in the Medical Specialties industry is in the same range as BLFS (95). This means that DCTH’s stock grew similarly to BLFS’s over the last 12 months.

BLFS's Profit vs Risk Rating (74) in the Medical Specialties industry is in the same range as DCTH (100). This means that BLFS’s stock grew similarly to DCTH’s over the last 12 months.

BLFS's SMR Rating (94) in the Medical Specialties industry is in the same range as DCTH (99). This means that BLFS’s stock grew similarly to DCTH’s over the last 12 months.

DCTH's Price Growth Rating (36) in the Medical Specialties industry is in the same range as BLFS (39). This means that DCTH’s stock grew similarly to BLFS’s over the last 12 months.

DCTH's P/E Growth Rating (1) in the Medical Specialties industry is in the same range as BLFS (14). This means that DCTH’s stock grew similarly to BLFS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLFSDCTH
RSI
ODDS (%)
Bullish Trend 4 days ago
61%
Bearish Trend 4 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
72%
Bullish Trend 4 days ago
80%
Momentum
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
79%
MACD
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 6 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
78%
View a ticker or compare two or three
Ad is loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DCTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HGIFX53.630.53
+1.00%
Hartford Core Equity F
LVOLX17.750.13
+0.74%
SGI US Large Cap Equity A
MMQYX8.250.05
+0.61%
MassMutual Small Cap Val Eq Svc
OSCYX22.320.13
+0.59%
Invesco Main Street Small Cap Y
CIHEX17.420.09
+0.52%
Calamos Hedged Equity I

BLFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with MASS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then MASS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLFS
1D Price
Change %
BLFS100%
+4.90%
MASS - BLFS
50%
Loosely correlated
+6.19%
RGEN - BLFS
49%
Loosely correlated
-1.42%
VCYT - BLFS
48%
Loosely correlated
+4.66%
AZTA - BLFS
48%
Loosely correlated
+1.88%
RDNT - BLFS
44%
Loosely correlated
+1.85%
More

DCTH and

Correlation & Price change

A.I.dvisor tells us that DCTH and ALC have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DCTH and ALC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DCTH
1D Price
Change %
DCTH100%
-1.52%
ALC - DCTH
33%
Poorly correlated
+0.69%
BLFS - DCTH
29%
Poorly correlated
+4.90%
ISRG - DCTH
27%
Poorly correlated
+0.10%
MMSI - DCTH
27%
Poorly correlated
+2.03%
OSSUY - DCTH
27%
Poorly correlated
N/A
More